Innovators Hour: Interview with Andrew Young & Allyson Mayer of Pairidex

biostl.org

February 18, 2026

By Jim McCarter

Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Andrew Young, MD, PhD, of Pairidex and WashU, and Allyson Mayer, PhD, of Pairidex and BioGenerator Ventures.

Pairidex is the developer of a droplet digital PCR assay designed to enable accurate detection of gene fusions in blood cancer.

Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights the people and ideas shaping St. Louis’ bioscience innovation ecosystem. Watch to discover groundbreaking startups, inspiring stories, and the future of bioscience in our region.

biostl.org
Newsletter: biostl.org/contact/contact-info-and-form
LinkedIn: linkedin.com/company/biostl Facebook: facebook.com/BioSTL/

About Pairidex

Pairidex® is a team of passionate problem-solvers working to make blood cancer care smarter, faster, and more compassionate. Our expertise spans genomics, oncology, and diagnostics, but it’s our shared dedication to making a real-world difference that sets us apart.

About Pairidex

Contact: hello@pairidex.com